Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etidronate in young patients with pseudoxanthoma elasticum
2021-000434-34Phase 3Active
- Sponsor
- University Medical Center Utrecht
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in pseudoxanthoma elasticum (PXE) comparing Etidronate with Placebo (2 arms). Primary endpoint: Total calcification score measured on low-dose CT in the legs and carotid siphons. Started Dec 2021; status: active.
02
Drugs
etidronate
03
Conditions
pseudoxanthoma elasticum (PXE)
Beyond the preview
Go deeper on 2021-000434-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000434-34.